Analyst Ratings for RXi Pharmaceuticals (RXII)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/9/2018 | H.C. Wainwright | N/A | New Coverage | Buy (N/A) |
3.00 (N/A) |
1.97 (0.33) |
-83.25% | Details |
| 6/2/2014 | Laidlaw | N/A | New Coverage | Buy (N/A) |
8.00 (N/A) |
2.79 (0.33) |
-88.17% | Details |
 |
||||||||
